Nan Shan Life Insurance’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-203,319
Closed -$20.2M 106
2019
Q3
$20.2M Sell
203,319
-61,500
-23% -$5.84M 0.56% 45
2019
Q2
$24.5M Hold
264,819
0.63% 48
2019
Q1
$25M Sell
264,819
-15,000
-5% -$1.31M 0.49% 51
2018
Q4
$17.9M Buy
279,819
+2,000
+0.7% +$148K 0.43% 52
2018
Q3
$24.9M Buy
277,819
+80,885
+41% +$7.15M 0.48% 48
2018
Q2
$15.6M Buy
196,934
+3,500
+2% +$291K 0.36% 54
2018
Q1
$17.3M Buy
193,434
+60,500
+46% +$5.81M 0.35% 61
2017
Q4
$13.9M Sell
132,934
-74,674
-36% -$8.43M 0.36% 50
2017
Q3
$30.3M Buy
207,608
+124,674
+150% +$17M 0.63% 39
2017
Q2
$10.8M Hold
82,934
0.27% 46
2017
Q1
$10.3M Hold
82,934
0.26% 51
2016
Q4
$9.6M Sell
82,934
-340,376
-80% -$37.9M 0.36% 41
2016
Q3
$44.2M Buy
423,310
+252,900
+148% +$27.4M 1.28% 22
2016
Q2
$16.8M Buy
170,410
+48,000
+39% +$4.97M 0.65% 31
2016
Q1
$12.3M Buy
+122,410
New +$12.6M 0.53% 39

Other funds holding CELG

Nan Shan Life Insurance's CELG Position: Q4 2019 in Review

Nan Shan Life Insurance sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 203,319 shares — an estimated $20.2M sold.

Nan Shan Life Insurance first reported a position in CELG in Q1 2016 and held it in 15 quarters. The position peaked at $44.2M in Q3 2016. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Nan Shan Life Insurance reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Nan Shan Life Insurance sold 203,319 Celgene Corp shares in Q4 2019, an estimated $20.2M.
  • Nan Shan Life Insurance first reported a position in Celgene Corp in Q1 2016 and held it in 15 quarters.
  • Nan Shan Life Insurance's Celgene Corp position peaked at $44.2M in Q3 2016.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Nan Shan Life Insurance's 13F filing for Q4 2019, filed 13 Feb 2020.